⁠Modernizing Traditional Chinese Medicine for Global Wellness: Science-Backed Herbal Health Solutions from Hong Kong to Belt and Road Markets

Founded in 2018 and headquartered at the Hong Kong Science Park, INFItech Limited is a health innovation company dedicated to modernizing Traditional Chinese Medicine (TCM) for global consumers. Through our consumer brand Cogniherbs (汉方新研), we translate centuries-old herbal wisdom into science-validated, high-quality health supplements that meet modern international standards.

Our Product Portfolio

We have developed three distinct product lines, each based on rigorously selected TCM herbal combinations:

•⁠ ⁠NerveReform (NR Series): Support neurological and cognitive health.

•⁠ ⁠MotionReform (TR Series): Support musculoskeletal and joint health.

•⁠ ⁠VascuReform (VR Series): Support cardiovascular and vascular health.

Each product line is available in multiple market-specific configurations, demonstrating our capability to adapt formulations and regulatory strategies to diverse international markets.

Proven Business Model

INFItech has established a successful cross-border e-commerce operation, reaching consumers across multiple markets. Our dual-channel strategy combines cross-border e-commerce with domestic distribution partnerships, allowing rapid market entry with lean capital efficiency. We have navigated regulatory frameworks across Asia-Pacific markets, building a replicable playbook for international expansion.

What We Are Looking For

1.⁠ ⁠Distribution Partners - Companies with local market access in Belt and Road countries interested in distributing premium TCM-based health products.

2.⁠ ⁠Strategic Investors - Capital partners who share our vision of TCM internationalization, with USD 1–5 million investment range for market expansion, R&D scaling, and regulatory certification.

3.⁠ ⁠Regulatory & R&D Collaborators - Institutions and service providers experienced in natural medicine registration, clinical validation, and cross-border health product compliance.

Why INFItech

•⁠ ⁠✅ Ready-to-scale products - Three commercially validated product lines, not concept-stage

•⁠ ⁠✅ Proven cross-border model - Revenue-generating e-commerce operations across multiple markets

•⁠ ⁠✅ Hong Kong-headquartered - Leveraging BRI's primary platform as our strategic base

•⁠ ⁠✅ Regulatory adaptability - Market-specific product variants already developed (e.g., Korea)

•⁠ ⁠✅ Alignment with policy tailwinds - Positioned at the intersection of TCM internationalization and natural medicine regulatory reform

Together, let us bring the wisdom of Traditional Chinese Medicine to the world - advancing wellness along the Belt and Road.